PIRET-LESSIRE PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PIRET-LESSIRE PHARMA
Largest movements
- Intangible fixed assets -€42,000
down €42,000 (-13.5%), from €311,260 to €269,260
- Receivables within one year +€40,218
up €40,218 (+54.8%), from €73,378 to €113,596
of which Trade receivables: +€40,465
- Cash +€32,006
up €32,006 (+46.6%), from €68,666 to €100,673
mainly Depreciation (+€44,055) and Trade debts (+€26,298)
- Debts after one year -€39,152
down €39,152 (-14.4%), from €271,563 to €232,411
- Trade debts +€26,298
up €26,298 (+113%), from €23,340 to €49,639
- Reserves +€25,523
up €25,523 (+102%), from €25,016 to €50,539
- Other debts +€8,180
up €8,180 (+4.8%), from €169,754 to €177,933
- Staff costs +€8,805
up €8,805 (+19.5%), from €45,211 to €54,017
- Gross operating margin +€6,740
up €6,740 (+5.0%), from €134,186 to €140,926
- Depreciation -€2,944
down €2,944 (-6.3%), from €47,000 to €44,055
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €551,438 | €574,336 | +€22,898 | +4.2% |
| Fixed assets | 21/28 | €313,316 | €269,260 | -€44,055 | -14.1% |
| Intangible fixed assets | 21 | €311,260 | €269,260 | -€42,000 | -13.5% |
| Tangible fixed assets | 22/27 | €2,055 | - | -€2,055 | |
| Plant, machinery and equipment | 23 | €2,055 | - | -€2,055 | |
| Current assets | 29/58 | €238,122 | €305,075 | +€66,953 | +28.1% |
| Stocks and contracts in progress | 3 | €96,079 | €90,639 | -€5,439 | -5.7% |
| Stocks | 30/36 | €96,079 | €90,639 | -€5,439 | -5.7% |
| Amounts receivable within one year | 40/41 | €73,378 | €113,596 | +€40,218 | +54.8% |
| Trade receivables | 40 | €65,319 | €105,784 | +€40,465 | +61.9% |
| Other amounts receivable | 41 | €8,059 | €7,812 | -€246 | -3.1% |
| Cash at bank and in hand | 54/58 | €68,666 | €100,673 | +€32,006 | +46.6% |
| Deferred charges and accrued income | 490/1 | - | €167 | +€167 | |
| Total equity and liabilities | 10/49 | €551,438 | €574,336 | +€22,898 | +4.2% |
| Equity | 10/15 | €30,016 | €55,539 | +€25,523 | +85.0% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €25,016 | €50,539 | +€25,523 | +102% |
| Distributable reserves | 133 | €25,016 | €50,539 | +€25,523 | +102% |
| Amounts payable | 17/49 | €521,422 | €518,797 | -€2,626 | -0.5% |
| Amounts payable after more than one year | 17 | €271,563 | €232,411 | -€39,152 | -14.4% |
| Financial debts | 170/4 | €271,563 | €232,411 | -€39,152 | -14.4% |
| Amounts payable within one year | 42/48 | €249,360 | €285,947 | +€36,587 | +14.7% |
| Current portion of amounts payable after more than one year | 42 | €41,605 | €42,382 | +€776 | +1.9% |
| Trade debts | 44 | €23,340 | €49,639 | +€26,298 | +113% |
| Suppliers | 440/4 | €23,340 | €49,639 | +€26,298 | +113% |
| Taxes, remuneration and social security | 45 | €14,661 | €15,994 | +€1,333 | +9.1% |
| Taxes | 450/3 | €8,589 | €9,418 | +€829 | +9.6% |
| Remuneration and social security | 454/9 | €6,072 | €6,576 | +€504 | +8.3% |
| Other amounts payable | 47/48 | €169,754 | €177,933 | +€8,180 | +4.8% |
| Accrued charges and deferred income | 492/3 | €499 | €438 | -€61 | -12.3% |
| Remuneration, social security and pensions | 62 | €45,211 | €54,017 | +€8,805 | +19.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €47,000 | €44,055 | -€2,944 | -6.3% |
| Other operating charges | 640/8 | €350 | €534 | +€184 | +52.7% |
| Gross operating margin | 9900 | €134,186 | €140,926 | +€6,740 | +5.0% |
| Operating profit (loss) | 9901 | €41,625 | €42,319 | +€694 | +1.7% |
| Financial income | 75/76B | €183 | €151 | -€31 | -17.1% |
| Recurring financial income | 75 | €183 | €151 | -€31 | -17.1% |
| Financial charges | 65/66B | €8,105 | €7,577 | -€529 | -6.5% |
| Recurring financial charges | 65 | €8,105 | €7,577 | -€529 | -6.5% |
| Profit (loss) for the period before taxes | 9903 | €33,702 | €34,894 | +€1,192 | +3.5% |
| Income taxes | 67/77 | €8,422 | €9,370 | +€948 | +11.3% |
| Profit (loss) for the period | 9904 | €25,280 | €25,523 | +€244 | +1.0% |
| Profit (loss) for the period to be appropriated | 9905 | €25,280 | €25,523 | +€244 | +1.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.